Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Effectiveness and safety of inpatient rehabilitation in patients with hematologic malignancies.
Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePatients with hematologic malignancies often experience significant physical deconditioning from intensive treatment and prolonged hospitalization. This study evaluated the safety and effectiveness of inpatient rehabilitation and examined the association between rehabilitation dose and functional outcomes.
methodsThis retrospective observational study included 34 inpatients with hematologic malignancies who received structured rehabilitation between January and December 2025. Functional capacity was assessed using the Cancer Functional Assessment Set (cFAS) before and after the intervention. Patients were stratified into three groups according to therapy dose: < 10, 10-20, and > 20 sessions.
resultsThe cohort (mean age = 61.6 years) demonstrated high systemic vulnerability, including anemia and hypoalbuminemia. Baseline characteristics were comparable across dose groups except for length of stay. Overall functional improvement was significant (p = 0.026). Mixed-effects ANOVA revealed a significant main effect of time and a significant group × time interaction, indicating greater functional gains with higher rehabilitation doses. Subgroup analysis identified significant improvement only in the > 20-session group (p = 0.022) but not in the < 10 (p = 0.950) or 10-20 (p = 0.125) groups. No major adverse events, including falls or bleeding, were observed despite low hematologic profiles.
conclusionStructured inpatient rehabilitation was safe and associated with functional improvement for patients with hematologic malignancies, even in the presence of severe systemic vulnerability. Our findings suggest a dose-associated pattern, with higher rehabilitation frequency associated with greater functional recovery, although interpreted cautiously given confounding by length of stay. These results may support early and consistent integration of rehabilitation into standard care to maximize physical recovery in patients hospitalized for hematologic malignancies.
Indexed as
Identifiers
42593686What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.